🎉 Celebrating 20 Years: Primacyt Cell Culture Technology GmbH 🎉

This month, we are thrilled to announce that Primacyt Cell Culture Technology GmbH is celebrating its 20th anniversary! 🎂

Since our founding in 2004, we have been dedicated to advancing cell culture technology, providing high-quality solutions for biomedical research, pharmaceutical industries, and related fields. Our products and services include:

• Hepatocyte Cultures: Offering high-quality human and animal hepatocytes to support drug screening, toxicity testing, and metabolic studies in human and animal health and environmental safety testing.
• Skin Tissues: Specializing in human and Cynomolgus skin cells and human ex vivo skin explants to provide reliable platforms for safety assessment of biocides, agrochemicals, cosmetic ingredients and characterization of topically applied pharmaceuticals.
• Liver-Related CRO Services: Focusing on early-stage drug development, we provide specialized liver cell services for toxicity assessments and metabolic research.

Over the past 20 years, we have grown from a small team to an industry leader, thanks to the hard work of our employees, the support of our clients, and the trust of our partners.

As we reflect on our achievements, we are grateful to everyone who has been with us on this journey. Our success is not only marked by technical advancements but also by the exceptional service and solutions we provide to our clients. Looking ahead, we remain committed to innovation and excellence, driving further advancements in cell culture technology and delivering superior services and products globally.

To celebrate this milestone, we have planned special events, including participation in the celebrations for the Day of German Unity from October 2^nd to October 4^th in Schwerin. We are looking forward revisiting the past and envisioning the future with all of you.

We would like to extend a special thank you to our team, clients, and all our partners. It is your support and trust that have made our success possible. Let’s look to the future together, embracing new challenges and opportunities!